Zobrazeno 1 - 10
of 229
pro vyhledávání: '"E Harari"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H Karameh, E Harari, Y Almagor, R Jubeh, M Shuvy, E Hellou, L Taha, A Butnaru, A Wolak, M Glikson, D Dvir
Publikováno v:
European Heart Journal. 43
Background Contemporary data comparing new- versus old-generation transcatheter heart valve (THV) devices are lacking regarding several THV devices. We aimed to compare the safety and efficacy of old-generation device (OGD) ACURATE neoTM versus the n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a43d33240a3f629e558922b11ac4b1
https://doi.org/10.1093/eurheartj/ehac544.1580
https://doi.org/10.1093/eurheartj/ehac544.1580
Publikováno v:
European Heart Journal. 43
Introduction Bioprosthetic valves are increasingly utilized during open heart surgery in favor of mechanical valves. These tissue valves are prone for structural valve degeneration and failure, especially in young patients. Transcatheter aortic valve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88264e75be5e6f66a366bfb8c649d0a2
https://doi.org/10.1093/eurheartj/ehac544.2151
https://doi.org/10.1093/eurheartj/ehac544.2151
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
O Shohat, A Wollak, R Wolff, E Harari, C Ben Ami, A Orlev, Danny Dvir, Y Steinmetz, Michael Glikson, I Vitkon Barkay
Publikováno v:
European Heart Journal. 42
Background Previous studies suggested that bioprosthetic valve commissural alignment may improve device performance and clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). However, no cath-lab method for correct c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21c749e0714a5854075dccdea6a66fcc
https://doi.org/10.1093/eurheartj/ehab724.2202
https://doi.org/10.1093/eurheartj/ehab724.2202
Publikováno v:
European Heart Journal. 42
Background Coronavirus disease 2019 (Covid-19) is associated with high incidence of thromboembolic events, both venous and arterial. Currently, there are no clinical or laboratory markers to guide antithrombotic therapy in COVID-19 patients. Immature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2c5f01ac034d7e6c280b6968df9250b
https://doi.org/10.1093/eurheartj/ehab724.1290
https://doi.org/10.1093/eurheartj/ehab724.1290
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohammad Abdollahi, F.F. Albaqami, K.M. Alharthy, H.N. Althurwi, P. Apalaki, Monica G. Arana-Puse, Asnida Arifin, Leonello Attias, Marek Banasik, Irene M. Baskerville-Abraham, Yasna Behmanesh, Yedidia Bentur, Tarryn Lee Botha, Aleksandra Buha Đorđević, Félix Carvalho, Fanny L. Casado, Kok Meng Chan, Tsun-Jen Cheng, Jang-Sik Choi, Cristiana L. Correa, Erdem Coskun, Vincent Danel, Yuri Bruinen de Bruin, Maurella Della Seta, Ana del Peso, Luz María Del Razo, Herbert Desel, John H. Duffus, Danijela Đukić-Ćosić, Jean-Christophe Gallart, Susana I. García, Nina Glaser, Choo Ta Goh, Maria E. Gonsebatt, Xinsheng Gu, Mary Gulumian, Adriana I. Haas, Homero C. Harari, Raul E. Harari, Carole Hirn, Lisa Hoffman, M. Hornychová, Toshime Igarashi, Salmaan Hussain Inayat-Hussain, Maryam Zare Jeddi, Carolina Juanena, Jahangir Kamaldin, Harriet Kamendi, Kh. Kh. Khamidulina, Shabnam Kharabaf, Jongwoon Kim, Lisbeth E. Knudsen, Kannan Krishnan, Jens Küllmer, B.A. Kurlyandskiy, Amalia Laborde, Birgitte Lindeman, Carlo Alessandro Locatelli, Ramiro I. Lopez, Sara Maisanaba, Stefan Mandić-Rajčević, Ida Marcello, Marina Marinovich, Vesna Matović, Asish Mohapatra, Diana Montenegro, Takeshi Morita, Marek Murias, Suresh K. Nagumalli, Alba Negrin, Shekoufeh Nikfar, Monica Nordberg, Magali Oliva-Labadie, Eren Ozcagli, R. Ponampalam, Pamela Prud’homme, Emmanuel Puskarczyk, Noor Amalina Ramle, Fernando Remião, Guillermo Repetto, Manuel Repetto, Juan Carlos Rios, Arisleida J. Rodríguez, Maritza Rojas, Raquel Rojas, Maristella Rubbiani, Jaana Rysä, Mazrura Sahani, Ulrich Schlottmann, Giuliana F.R. Selmi, Yoshiyuki Shigeta, Hyun Kil Shin, K.K. Sidorov, Lorena Silva, Jorge Soares, Sandra Solari, Todd Stedeford, Douglas M. Templeton, A.M. Tsatsakis, E. Vakonaki, Jan van der Kolk, Maylin E. Velásquez, J. Veselá, Edda C. Villaamil Lepori, Matti Viluksela, M. Vysloužilová, Jung-Der Wang, Victor Wepener, Philip Wexler, Lars Wiklund, Paul F.A. Wright, Chen-Chang Yang, Seokjoo Yoon, Tae Hyun Yoon, Flavio A.D. Zambrone, Joseph Zayed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36280e0b048ad74949094561105c5a21
https://doi.org/10.1016/b978-0-12-821611-8.00053-x
https://doi.org/10.1016/b978-0-12-821611-8.00053-x
Autor:
A Schechter, Alon Eisen, Nir Shlomo, E Harari, Zaza Iakobishvili, Ran Kornowski, O Itzhaki Ben Zadok, Oren Zusman
Publikováno v:
European Heart Journal. 40
Background Patients with prior myocardial infarction (MI) are at increased risk for recurrent cardiovascular events. Advances in treatment in the last decade has improved prognosis of patients with acute coronary syndrome (ACS), yet it is not known w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5fc5643ea118bdf6f2130cdd8d32531
https://doi.org/10.1093/eurheartj/ehz745.0466
https://doi.org/10.1093/eurheartj/ehz745.0466